LivaNova (LIVN) Shares Outstanding (Weighted Average) (2014 - 2026)
LivaNova recorded quarterly Shares Outstanding (Weighted Average) of $54.7 million in Q1 2026, little changed quarter-over-quarter from $54.5 million in Q4 2025, and little changed year-over-year from $54.4 million in Q1 2025.
LivaNova's Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $54.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) changed 0.49% year-over-year to $54.7 million; the TTM figure through Mar 2026 stood at $54.7 million (changed 0.49% YoY), while the FY2025 annual figure was $54.5 million, up 0.57% from the prior year.
- Shares Outstanding (Weighted Average) came in at $54.7 million for Q1 2026 at LivaNova, roughly flat from $54.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $54.7 million in Q1 2026 to a low of $53.3 million in Q1 2022.
- A 5-year average of $54.0 million and a median of $54.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) advanced 9.36% in 2022 and rose 0.33% in 2025, its largest moves.
- LivaNova's Shares Outstanding (Weighted Average) stood at $53.5 million in 2022, then rose by 0.87% to $53.9 million in 2023, then rose by 0.56% to $54.2 million in 2024, then grew by 0.57% to $54.5 million in 2025, then increased by 0.26% to $54.7 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $54.7 million, $54.5 million, and $54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 54.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.69 Mn |
| Dec 31, 2025 | 54.55 Mn |
| Sep 30, 2025 | 54.53 Mn |
| Jun 30, 2025 | 54.50 Mn |
| Mar 31, 2025 | 54.42 Mn |
| Dec 31, 2024 | 54.24 Mn |
| Sep 30, 2024 | 54.35 Mn |
| Jun 30, 2024 | 54.24 Mn |
| Mar 31, 2024 | 54.01 Mn |
| Dec 31, 2023 | 53.94 Mn |
| Sep 30, 2023 | 53.84 Mn |
| Jun 30, 2023 | 53.80 Mn |
| Mar 31, 2023 | 53.62 Mn |
| Dec 31, 2022 | 53.47 Mn |
| Sep 30, 2022 | 53.53 Mn |
| Jun 30, 2022 | 53.51 Mn |
| Mar 31, 2022 | 53.30 Mn |
| Dec 31, 2021 | 50.63 Mn |
| Sep 30, 2021 | 51.58 Mn |
| Jun 30, 2021 | 48.93 Mn |
| Mar 31, 2021 | 48.74 Mn |
| Dec 31, 2020 | 48.59 Mn |
| Sep 30, 2020 | 48.65 Mn |
| Jun 30, 2020 | 48.61 Mn |
| Mar 31, 2020 | 48.49 Mn |
| Dec 31, 2019 | 48.35 Mn |
| Sep 30, 2019 | 48.33 Mn |
| Jun 30, 2019 | 48.30 Mn |
| Mar 31, 2019 | 48.25 Mn |
| Dec 31, 2018 | 48.50 Mn |
| Sep 30, 2018 | 48.64 Mn |
| Jun 30, 2018 | 48.41 Mn |
| Mar 31, 2018 | 48.32 Mn |
| Dec 31, 2017 | 48.16 Mn |
| Sep 30, 2017 | 48.18 Mn |
| Jun 30, 2017 | 48.14 Mn |
| Mar 31, 2017 | 48.07 Mn |
| Dec 31, 2016 | 48.86 Mn |
| Sep 30, 2016 | 49.08 Mn |
| Jun 30, 2016 | 49.06 Mn |
| Mar 31, 2016 | 48.92 Mn |
| Dec 31, 2015 | 32.74 Mn |
| Oct 18, 2015 | 26.02 Mn |
| Jul 24, 2015 | 26.00 Mn |
| Apr 24, 2015 | 26.39 Mn |
| Dec 26, 2014 | 26.55 Mn |
| Oct 24, 2014 | 26.64 Mn |
| Apr 25, 2014 | 27.14 Mn |